correlate the serum level of statin and SGLT2i when given as polytherapy with HPLC in ischemic heart failure patients and their laboratory tests (cholesterol, LDL, HDL and TG...)
we include patients established ischemic heart failure seen by a primary care provider to diagnose ischemic heart disease,
They assessed the use of statin with SGLT2i.
We exclude patients with
liver dysfunction.
renal dysfunction.
fungal infection.
the health care provider asks about patient's symptoms which may experience: * Chest pain, especially after physical exertion * Dizziness or fainting * Heart palpitations, which may feel like your heart fluttering or skipping beats * Shortness of breath * Swelling in your feet or ankles * brain natriuretic peptide (BNP) with 70% sensitivity and 99% specificity and N-terminal proBNP (NT-proBNP) with 99% sensitivity and 85% specificity which are Other HF-specific laboratory tests (especially in patients with a high possibility of heart failure) included. (18) * chest X-ray, transthoracic echocardiography (TTE), computerized tomography (CT) scans and magnetic resonance imaging (MRI) also other diagnostic tests for HF. (19)
Case-only
Other
Statin and SGLT2i
DrugStatin as atrovastatin SGLT2i as dapagliflozin
The Effect of The combination Therapy of Statin and SGLT2i in The Treatment of Ischemic Heart disease
correlate the serum level of statin and SGLT2i when given as polytherapy with ECG in ischemic heart failure patients and their laboratory tests (cholesterol, LDL, HDL and TG...)
Click on the lead sponsor to view all of their trials.
